3Q23 Revenues Report: Bioton Sees a 12% YoY Decline, Driven by Insulin Sales Drop of 18%FOREXGPW’s Analytical Coverage Support Programme 3.0
Bioton's 3Q23 Financial Performance: Below Expectations with Production Downtime ImpactFOREXGPW’s Analytical Coverage Support Programme 3.0
Challenges and Opportunities: Bioton's 3Q23 Earnings Forecast Amidst Evolving Market DynamicsFOREXGPW’s Analytical Coverage Support Programme 3.0
WSE: Bioton – (Last valuation: 5.34 PLN/share as of 20.04.2023)STOCKSGPW’s Analytical Coverage Support Programme 3.0
14:14 10.04Bitget Launches Bitget Onchain to Give CEX Users Early Access to Promising On-chain Assets
09:45 10.04Hola Prime Expands into On-Exchange Cryptos, Bringing Centralized Exchange Access to Crypto Traders
15:26 08.04Rebuilding EUR Longs, Shorting CAD: Long EURCAD for Growth Divergence and Positioning Asymmetry
